Chemoinformaics analysis of ISOPIMARA-7,15-DIENE
| Molecular Weight | 272.476 | nRot | 1 |
| Heavy Atom Molecular Weight | 240.22 | nRig | 17 |
| Exact Molecular Weight | 272.25 | nRing | 3 |
| Solubility: LogS | -6.001 | nHRing | 0 |
| Solubility: LogP | 6.774 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 54.7374 |
| nHD | 0 | BPOL | 32.1026 |
| QED | 0.503 |
| Synth | 4.315 |
| Natural Product Likeliness | 3.634 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.655 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.489 |
| MDCK | 0.0000163 |
| BBB | 0.053 |
| PPB | 0.948747 |
| VDSS | 1.131 |
| FU | 0.0429566 |
| CYP1A2-inh | 0.189 |
| CYP1A2-sub | 0.279 |
| CYP2c19-inh | 0.245 |
| CYP2c19-sub | 0.904 |
| CYP2c9-inh | 0.364 |
| CYP2c9-sub | 0.284 |
| CYP2d6-inh | 0.597 |
| CYP2d6-sub | 0.398 |
| CYP3a4-inh | 0.937 |
| CYP3a4-sub | 0.384 |
| CL | 7.728 |
| T12 | 0.031 |
| hERG | 0.019 |
| Ames | 0.002 |
| ROA | 0.144 |
| SkinSen | 0.151 |
| Carcinogencity | 0.469 |
| EI | 0.639 |
| Respiratory | 0.951 |
| NR-Aromatase | 0.299 |
| Antiviral | No |
| Prediction | 0.617473 |